๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› India
Clinical trial register · India

Studies with an Indian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1126 matching records held by the registry are in this view. Synced 23 Sep 2026, 03:16 UTC
1126
Studies in scope
all four open statuses
611
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 334 Mumbai 258 Hyderabad 237 Bangalore 195 Pune 189
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca100 Institute of Liver and Biliary Sciences, India48 Postgraduate Institute of Dental Sciences Rohtak45 Novartis Pharmaceuticals44 Tata Memorial Centre41
Site location
New Delhi334 Mumbai258 Hyderabad237 Bangalore195 Pune189
All 273 locations
Target enrolment
to
1126 of 1126 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Active, closed
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
NCT06120491Metastatic Castration-Sensitive Prostate Cancer
AstraZeneca
Phase 3
1,898
Bangalore, Calicut, Kanpur, Kolkata, Nagpur, New Delhi, Pune, Vadodara
2023-11-21
Active, closed
The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis
NCT06168097Endometriosis
Asian Institute of Gastroenterology, India
Not applicable
200
Hyderabad
2023-11-15
Active, closed
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.
NCT06042478Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Phase 3
470
Ahmedabad, Bangalore, Belagavi, Mysore, Nagpur, Nashik, New Delhi, Bikaner
2023-11-15
Active, closed
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
NCT06112379Breast Cancer
AstraZeneca
Phase 3
1,902
Bengaluru, Delhi, Kolkata, Marg Jaipur, Nagpur, Nashik, Thiruvananthapuram, Vadodara
2023-11-14
Recruiting
A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
NCT06016452Diffuse Glioma, Radionecrosis of Brain, High Grade Glioma, Glioblastoma Multiforme
Tata Memorial Centre
Phase 2
118
Mumbai
2023-11-13
Active, closed
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
NCT06161571NASH/MASH, NAFLD/MASLD
Akero Therapeutics, Inc
Phase 3
700
Surat, Vadodara, Thiruvananthapuram, Dahegaon, Mumbai, Nagpur, Pune, New Delhi
2023-11-10
Active, closed
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
NCT05925803Systemic Sclerosis, Scleroderma
AstraZeneca
Phase 3
314
Ahmedabad, Delhi, Gurugram, Hyderabad, Kolkata, Mumbai, Mysuru, New Delhi
2023-11-08
Active, closed
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
NCT06087835Chronic Kidney Disease With High Proteinuria
AstraZeneca
Phase 3
1,835
Bangalore, Belagavi, Delhi, Nadiฤd, New Delhi
2023-11-07
Not yet open
Ovary Syndrome for Efficient Diagnosis and Targeted Therapy
NCT06102629Polycystic Ovary Syndrome
Asian Institute of Gastroenterology, India
Not applicable
200
Hyderabad
2023-11-05
Recruiting
Effect Of High Magnification On Quality Of Life And Success After Endodontic Microsurgery: A Randomized Controlled Trial
NCT06642415Periapical Lesion
Postgraduate Institute of Dental Sciences Rohtak
Not applicable
40
Rohtak
2023-11-01
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Gandhinagar, Bangalore, Pune, Hyderabad
2023-11-01
Recruiting
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
NCT06095492Kidney Transplant; Complications, Diabetes Mellitus
Medanta, The Medicity, India
Not applicable
200
Gurgaon
2023-10-30
Recruiting
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
NCT06060392Liver Transplant; Complications, Diabete Mellitus
Medanta, The Medicity, India
Not applicable
50
Gurgaon
2023-10-30
Active, closed
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
NCT05985915Sjogrens Syndrome
Novartis Pharmaceuticals
Phase 3
612
Ahmedabad, New Delhi
2023-10-27
Active, closed
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
NCT06025578Progressive Pulmonary Fibrosis
Bristol-Myers Squibb
Phase 3
1,057
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-10-25
Active, closed
A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
NCT06108219Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH)
Corcept Therapeutics
Phase 2
175
Guwahati, Ahmedabad, Rajkot, Surat, Vadodara, Rohtak, Mysore, Thiruvananthapuram
2023-10-25
Active, closed
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.
NCT05984277Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 3
895
Bengaluru, Hyderabad, Kolkata, Mysuru, Nagpur, Varanasi
2023-10-24
Active, closed
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
NCT05949684Myelodysplastic Syndromes
Bristol-Myers Squibb
Phase 3
402
Ahmedabad, Bengaluru, New Delhi, Bhubaneswar
2023-10-24
Active, closed
A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares
NCT06013969Generalized Pustular Psoriasis
LEO Pharma
Phase 4
42
Bikaner, Nagpur
2023-10-22
Recruiting
A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
NCT05984147Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited
Phase 1
40
Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Srinagar, Belagavi, Kochi
2023-10-19
Recruiting
Predictive Accuracy of PLR and PNR in Detecting ETIC
NCT07046858Trauma Injury, Coagulopathy
Jubilee Mission Medical College and Research Institute
Observational
250
Thrissur
2023-10-17
Recruiting
Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes
NCT06035874Type 2 Diabetes, Non Alcholic Fatty Liver Disease
Medanta, The Medicity, India
Not applicable
100
Gurgaon
2023-10-15
Active, closed
Harmony: A Combined MI and BCT Intervention to Reduce Intimate Partner Violence and Alcohol Use in South India
NCT05893277Intimate Partner Violence, Alcohol Use Disorder
University of California, San Francisco
Not applicable
800
Bangalore
2023-10-12
Active, closed
Impact of Food Insecurity on Utilization of Maternal Healthcare Services and Birth Outcomes in Slums in Pune, India
NCT06313112Prenatal Care, Food Insecurity, Pregnancy Outcome
Hirabai Cowasji Jehangir Medical Research Institute
Observational
200
Pune
2023-10-09
Active, closed
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
NCT05952557Breast Cancer, Early Breast Cancer
AstraZeneca
Phase 3
5,511
Ansฤrinagar, Bangalore, Dehradun, Delhi, Kolkata, Kozhikode, Mumbai, Mysuru
2023-10-05
Recruiting
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
NCT05755386IC-MPGN
Novartis Pharmaceuticals
Phase 3
106
Bangalore, Nagpur, Pune, New Delhi, Hyderabad
2023-10-02
Not yet open
Efficacy and Safety of Radiofrequency Pallidotomy in the Management of Dystonia
NCT06038097Dystonia
All India Institute of Medical Sciences
Not applicable
72
New Delhi
2023-10-01
Recruiting
Cervical Fixation Surgery Cervical Collar for Management of Hirayama Disease: A Randomized Study
NCT05959980Hirayama Disease
All India Institute of Medical Sciences
Not applicable
80
New Delhi
2023-10-01
Recruiting
Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis
NCT06066372Choledocholithiasis
Asian Institute of Gastroenterology, India
Observational
1,000
Hyderabad
2023-10-01
Recruiting
Smartphone Use Restriction as Treatment of Primary Headache
NCT06041997Headache Disorders
All India Institute of Medical Sciences
Not applicable
60
New Delhi
2023-10-01
Recruiting
Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.
NCT07708987Hematological Malignancy, GVHD - Graft-Versus-Host Disease, Steriod Refractory
Tata Memorial Centre
Phase 2
34
Navi Mumbai
2023-09-23
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
NCT06079671Locally Advanced Cervical Cancer
AstraZeneca
Phase 3
800
Calicut, Jaipur, Lucknow, Madurai, Mohali, Nagpur, Nashik, New Delhi
2023-09-22
Active, closed
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
NCT06003426Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb
Phase 3
1,255
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-09-14
Recruiting
NMR Based Metabolomics Kinetics in ARDS Patients
NCT06036056ARDS
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Observational
120
Lucknow
2023-09-13
Recruiting
Artificial Intelligence in CNS Radiation Oncology
NCT06036394CNS Tumor
Tata Memorial Centre
Observational
6,000
Mumbai
2023-09-13
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
NCT05894239Metastatic Breast Cancer
Hoffmann-La Roche
Phase 3
230
Ahmedabad, Surat, Gurugram, Mumbai, Nagpur, NEW Delhi Delhi, Kolkata
2023-09-08
Recruiting
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
NCT05514340Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy
Pharmazz, Inc.
Phase 2
40
Mangalore, Ludhiana, Hyderabad, Kanpur
2023-09-06
Recruiting
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
NCT05865002Relapsed Malignant Solid Neoplasm
Aurigene Discovery Technologies Limited
Phase 1
50
Vijayawada, Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Bangalore, Mysore
2023-09-05
Recruiting
Comorbidities Resolution After MGB Surgery and Change in Body Composition
NCT06015620Morbid Obesity, Type2diabetes, Sleep Apnea, Hypothyroidism
All India Institute of Medical Sciences, Bhubaneswar
Observational
35
Bhubaneswar
2023-09-01
Recruiting
Outcome of Bone Window Approach in Endodontic Microsurgery Using Novel Piezoelectric Device
NCT06587048Periapical Lesions, Chronic Apical Periodontitis of Pulpal Origin
Postgraduate Institute of Dental Sciences Rohtak
Not applicable
40
Rohtak
2023-09-01
Recruiting
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
NCT07021677T Acute Lymphoblastic Leukemia
Tata Memorial Centre
Phase 2
18
Navi Mumbai
2023-08-28
Recruiting
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
NCT05681026Hematopoietic Stem Cell Transplantation, Cancer
M.D. Anderson Cancer Center
Not applicable
60
Giddenahalli
2023-08-28
Recruiting
Pituitary Function After Recovery From Septic Shock Among ICU Survivors
NCT05990491Shock, Septic, Pituitary Dysfunction, Hypopituitarism
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Observational
90
Lucknow
2023-08-28
Recruiting
Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
NCT07400809Chemotherapy, Treatment Compliance, Radiotherapy, Cervix Cancer
Tata Memorial Hospital
Observational
350
Mumbai
2023-08-23
Recruiting
Character-Strengths Based Coaching For Work-Stress Reduction For Health Workers
NCT06013488Work Related Stress, Burnout, Psychological, Mental Health Issue
Templeton World Charity Foundation
Not applicable
330
Bhopal
2023-08-21
Recruiting
Onabotulinum Toxin A (Botox) in the Treatment of Pharyngo-esophageal Dysphagia
NCT04695600Transfer Dysphagia, Oropharyngeal Dysphagia, Cricopharyngeus Muscle Dysfunction
All India Institute of Medical Sciences
Phase 2/3
100
New Delhi
2023-08-11
Active, closed
S.T.O.P.ยฎ Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children
NCT05243836Myopia
nthalmic Pty Ltd
Not applicable
441
Hyderabad
2023-08-04
Recruiting
Clinical Application of Artificial Intelligence in New Borns With Cleft Lip and Palate
NCT06970158Congenital Disorder, Cleft Lip Palate
University Hospital, Basel, Switzerland
Not applicable
70
Chennai, Hyderabad
2023-08-01
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
NCT05855200Colonic Neoplasms, Neoplasms, Colon
GlaxoSmithKline
Phase 3
892
Bengaluru, Ludhiana, Belagavi, Hyderabad, Nashik, Pune
2023-08-01
Recruiting
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
NCT07062263Biliary Tract Cancer, HER2-positive Cancer, Advanced Cancer, Unresectable Biliary Tract Carcinoma
Tata Memorial Centre
Phase 3
220
Muzaffarpur, Mumbai, Bhubaneswar, Mลซllฤnpur, Varanasi, Delhi
2023-07-21
Active, closed
Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients
NCT05118490HIV Seropositivity, Tuberculosis, Household Contact
The Aurum Institute NPC
Phase 4
1,000
Pune
2023-07-19
Recruiting
Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology
NCT06095466Cirrhotic Cardiomyopathy, Cirrhosis, Liver, Cardiac Disease
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
150
Sector-12
2023-07-15
Recruiting
Cardiac Dysfunction in Patients with Fatty Liver Disease
NCT06386094NAFLD, Cardiac Disease, Fatty Liver, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
150
Chandigarh
2023-07-15
By invitation
A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
NCT05921162Retinitis Pigmentosa, Retinal Disease, Retinal Degeneration
Nanoscope Therapeutics Inc.
Observational
11
Cuttack
2023-07-14
Active, closed
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
NCT05819866Cerebral Adrenoleukodystrophy (cALD)
Minoryx Therapeutics, S.L.
Phase 3
40
New Delhi
2023-07-12
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Nagpur, Chandigarh, Ajmer, Hyderabad, Kolkata, Varanasi
2023-07-11
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow
2023-07-06
Active, closed
SCRT in TNT With or Without Chlorophyllin
NCT05856305Rectal Neoplasms
Tata Memorial Centre
Phase 2
76
Mumbai
2023-07-05
Recruiting
Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System
NCT04861805Symptomatic Aortic Stenosis
P+F Products + Features GmbH
Not applicable
267
Bangalore, Gurgaon, Jaipur, Kochi, Vellore
2023-07-03
Recruiting
PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS
NCT06923098Lung Diseases
All India Institute of Medical Sciences, Bhubaneswar
Not applicable
108
Bhubaneswar
2023-07-01
Recruiting
Surface Topography and Color Stability of Implant Supported 3D Printed Provisional Restorations
NCT06947070DENTAL IMPLANTATION
Postgraduate Institute of Dental Sciences Rohtak
Not applicable
24
Rohtak
2023-07-01
Active, closed
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche
Phase 3
2,000
Hyderabad, Ahmedabad, Faridabad, Hubli, Nagpur, Pune, Ajmer, Jaipur
2023-06-28
Recruiting
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
NCT06016946Friedreich Ataxia
Friedreich's Ataxia Research Alliance
Observational
3,000
New Delhi
2023-06-28
Active, closed
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
NCT05966480SLE
Alumis Inc
Phase 2
408
New Delhi, Ahmedabad, Bangalore, Bengaluru, Chandigarh, Haryฤna, Jaipur, Lucknow
2023-06-26
Active, closed
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
NCT05672576Lupus Erythematosus, Systemic
Viatris Innovation GmbH
Phase 3
451
Ahmedabad, Chennai, Hyderabad, Kolkata, Nagpur, Nashik, New Delhi, Pune
2023-06-26
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
NCT05427370Coronary Artery Disease, Heart Failure Systolic
Sunnybrook Health Sciences Centre
Not applicable
754
Palayam
2023-06-22
Active, closed
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
NCT05827016Multiple Myeloma
Bristol-Myers Squibb
Phase 3
1,230
Chandigarh, Bangalore, Kochi, Kolhฤpur, Nagpur, Pune, Bhubaneswar, Kolkata
2023-06-22
Recruiting
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
NCT05701358Acute Myocardial Infarction, Coronary Artery Disease
Population Health Research Institute
Not applicable
5,100
Ernฤkulam, Kollam, Kottayam, Indore, Jaipur, Chennai, Madurai, Hyderabad
2023-06-22
Recruiting
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
NCT05953584Sickle Cell Disease
Forma Therapeutics, Inc.
Phase 2
27
Raipur, Delhi, Gujarat, Maharashtra, Nagpur
2023-06-20
Active, closed
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT05869903Obesity, Overweight, Overweight or Obesity
Eli Lilly and Company
Phase 3
3,127
Guntur, Bangalore, Mysore, Nagpur, Pune
2023-06-05
Active, closed
A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (ฮฒ-Thal) in India
NCT05891249Anemia
Bristol-Myers Squibb
Phase 4
85
Ahmedabad, New Delhi, Kolkata, Assam, Bangalore, Chandigarh, Delhi, Hyderabad
2023-06-05
Recruiting
Feasibility Clinical Evaluation of the Calibreye System
NCT05885022Glaucoma, Open-Angle
Myra Vision Inc.
Not applicable
60
Chennai
2023-05-31
Recruiting
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
NCT05857631Cervical Cancer, Endometrial Cancer
Tata Memorial Centre
Not applicable
90
Navi Mumbai, Mumbai
2023-05-29
Recruiting
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
NCT05895786Myositis
Pfizer
Phase 3
318
Gurugram (Gurgaon), Kochi, Kolkata
2023-05-20
Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05850689Major Depressive Disorder
Intra-Cellular Therapies, Inc.
Phase 3
470
Ahmedabad, Ajmer, Bฤrฤmati, Bikaner, Chandigarh, Guwahati, Kolhฤpur, Nagpur
2023-05-02
Active, closed
SODium BICarbonate for Metabolic Acidosis in the ICU
NCT05697770Metabolic Acidosis, Shock
Australian and New Zealand Intensive Care Research Centre
Phase 3
500
Puducherry, Ludhiana
2023-04-26
Recruiting
Yoga Based Cardiac Rehabilitation in Heart Failure Failure
NCT07817589Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class II, Heart Failure NYHA Class III
Centre for Chronic Disease Control, India
Not applicable
3,500
Dharwad, Mysore, Shillong, New Delhi, Ludhiana, Jodhpur, Chennai, Rishikesh
2023-04-24
Active, closed
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
NCT05624749Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
288
Ahmedabad, Kozhikode, Kolhฤpur, Nagpur, Nashik, Pune, New Delhi, Dehradun
2023-04-21
Active, closed
Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.
NCT05817110Lung Malignancy
AstraZeneca
Observational
712
Gurugram, New Delhi, Hyderabad, Bangalore, Chennai, Kolkata, Mumbai, Pune
2023-04-20
Recruiting
A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
NCT05515367Chronic Kidney Diseases, Anemia of Chronic Kidney Disease
Zydus Lifesciences Limited
Phase 4
1,004
Sheikhpura
2023-04-20
Recruiting
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
NCT05639647Gram-negative Bacterial Infections
Pfizer
Phase 2
48
Bangalore, Lucknow, Kolkata
2023-04-18
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Coimbatore, Hyderabad
2023-04-17
Active, closed
TrEatment Approach in the Multimodal Era Registry
NCT05629052Chronic Thromboembolic Pulmonary Hypertension, CTEPH
International CTEPH Association
Observational
1,000
Bangalore
2023-04-12
Active, closed
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869Atrial Fibrillation
Janssen Research & Development, LLC
Phase 3
20,284
Aligarh, Amritsar, Aurangabad, Bangalore, Belagavi, Bengaluru, Bikaner, Chennai
2023-04-11
Active, closed
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT05769777Dermatitis Atopic
Sanofi
Phase 2
999
Bengaluru, Bikaner, Kochi, Kolkata, Mangaluru, Nashik, Surat
2023-04-03
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
NCT05774951Breast Cancer, Early Breast Cancer
AstraZeneca
Phase 3
4,300
Bangalore, Belagavi, Bhubaneswar, Hubli, Hyderabad, Jaipur, Kolkata, Mumbai
2023-03-31
Active, closed
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05572515Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Phase 3
614
Gurgaon, Jaipur, Pune
2023-03-29
Active, closed
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guรฉrin (BCG) in Participants With BCG-naรฏve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
NCT05714202Bladder Cancer
Janssen Research & Development, LLC
Phase 3
1,135
Bangalore, Chandigarh, Gurugram, Kolkata, Mumbai, Pune
2023-03-23
Recruiting
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
NCT05776069Von Willebrand Diseases
Vega Therapeutics, Inc
Phase 1/2
116
Sion
2023-03-16
Recruiting
BPH Global Registry
NCT05543200Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Sociรฉtรฉ Internationale d'Urologie
Observational
7,500
Delhi
2023-03-13
Recruiting
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
NCT05696613Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc.
Phase 3
148
Guntur, Nellore, Raipur, Nadiฤd, Belagavi, Nagpur, New Delhi, Chandigarh
2023-03-13
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Guntur, Ahmedabad, Bangalore, Belagavi, Mangalore, Manipal, Mysore, Kochi
2023-03-09
Recruiting
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
NCT05744921Paroxysmal Nocturnal Hemoglobinuria
Regeneron Pharmaceuticals
Phase 3
202
Kochi, Mumbai, New Delhi, Chandigarh, Jaipur
2023-03-07
Active, closed
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
NCT05654623Advanced Breast Cancer
Pfizer
Phase 3
624
Gurgaon, Mumbai, Nashik, Thane, New Delhi, Kolkata
2023-03-03
Active, closed
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
NCT05669755Cardiovascular Disease
Novo Nordisk A/S
Phase 3
7,101
Guntur, Hyderabad, Vijayawada, Guwahati, Raipur, Ahmedabad, Surat, Vadodara
2023-03-01
Active, closed
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC
Phase 3
12,523
Ahmedabad, Ajmer, Anand, Bangalore, Belagavi, Bhubaneswar, Bikaner, Chennai
2023-02-15
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Surat, Mumbai, Pune, Ludhiana, Jaipur, Ranipet, Noida
2023-02-13
Active, closed
Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Strictures
NCT05521867Crohn Disease
Asian Institute of Gastroenterology, India
Not applicable
96
Hyderabad
2023-02-10
Active, closed
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
NCT05605535Ovarian Neoplasm Epithelial, Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Carcinoma
CanariaBio Inc.
Phase 2
88
Visakhapatnam, Vadodara, Belagavi, Kochi, Trivandrum, Puducherry, Jaipur, Chennai
2023-02-07
Active, closed
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
NCT05653349Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals
Phase 3
226
Ahmedabad, Rishikesh
2023-02-03
Rows per page Showing 701–800 of 1126
Previous 6 7 8 9 10 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-india?page=8

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (19) Obesity (16) Heart Failure (14) Carcinoma, Non-Small-Cell Lung (14) Overweight (13) Cervical Cancer (12) Non-Small Cell Lung Cancer (11) Liver Cirrhosis (10) Chronic Kidney Disease (9) Diabetes Mellitus, Type 2 (9) Ulcerative Colitis (8) Coronary Artery Disease (8) Periodontitis (7) Schizophrenia (7) Multiple Myeloma (7)
→

Browse trials by site location

New Delhi (334) Mumbai (258) Hyderabad (237) Bangalore (195) Pune (189) Kolkata (166) Ahmedabad (157) Nagpur (123) Jaipur (104) Chandigarh (104) Nashik (99) Delhi (97) Belagavi (91) Chennai (88) Surat (86)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.